PTIX – protagenic therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Protagenic Therapeutics, For: Feb 03
Form 8-K Protagenic Therapeutics, For: Feb 17
Form NT 10-Q Protagenic Therapeutics, For: Dec 31
Form 25-NSE Protagenic Therapeutics, Filed by: Nasdaq Stock Market LLC
Form 8-K Protagenic Therapeutics, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.